3.56 Quality of Control Groups in RCTs of Multiple Myeloma with Dr. Ghulam Rehman Mohyuddin


Today we interview Dr. Ghulam Rehman Mohyuddin of Kansas University Medical Center on his new paper out now in The Lancet Haematology titled "Quality of control groups in randomised trials of multiple myeloma enrolling in the USA: a systematic review".


Previous
Previous

3.57 Career Paths and Evolution of the Oncology Randomized Clinical Trial with Dr. Christopher Booth

Next
Next

3.55 Equity in Vaccine Distribution, Cancel Culture, and Zero COVID-19 with Dr. Matthew Smith